Lynwood Capital Management’s Inhibikase Therapeutics IKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,000	Closed	-$178K	–	150
2022 Q1	$178K	Sell	20,000 -22,500	-53%	-$200K	0.19%	90
2021 Q4	$375K	Buy	+42,500	New	+$375K	0.36%	67